Nishiyama Tomoki
Department of Anesthesiology and Critical Care, Kamagaya General Hospital, Kamagaya, Chiba, Japan.
Eur J Pharmacol. 2009 Jul 1;614(1-3):122-7. doi: 10.1016/j.ejphar.2009.03.041. Epub 2009 Mar 24.
Serotonin (5-HT)(2A) receptors are involved in cytokine production in infection or sepsis. Therefore, 5-HT(2A) receptor antagonist might be useful to treat sepsis. The present study investigates the effects of a 5-HT(2A) receptor antagonist, sarpogrelate on endotoxin shock. Catheters were inserted into the femoral artery and vein of Sprague-Dawley rats. First, sarpogrelate 0 (control), 3, or 10 mg/kg dissolved in 0.5 ml of distilled water has been given, followed by endotoxin 10 mg/kg in saline 0.5 ml 5 min later. Blood pressure, pulse rate and survival rate were monitored in 20 rats per dose. Blood gas and plasma cytokine concentrations were measured in 8 rats per dose. In four rats each of sarpogrelate 0, 3, or 10 mg/kg, and sham operation, the lung histology was examined. Zero, 15, and 12 rats survived for 8 h in the control, 3 mg/kg, and 10 mg/kg groups, respectively. The control group had the lowest blood pressure, pulse rate, pH and arterial oxygen tension, and the highest arterial carbon dioxide tension and plasma IL-1beta concentration. The increase of TNF-alpha was significantly lower in 3 mg/kg group than in the control group. Pathological changes of the lung were inhibited in 3 and 10 mg/kg groups. In conclusion, sarpogrelate might be effective to decrease production of pro-inflammatory cytokines, to keep hemodynamics, to inhibit lung damage, and to decrease mortality in endotoxin shock.
血清素(5-羟色胺,5-HT)(2A) 受体参与感染或脓毒症中的细胞因子生成。因此,5-HT(2A) 受体拮抗剂可能对治疗脓毒症有用。本研究调查了一种5-HT(2A) 受体拮抗剂——沙格雷酯对内毒素休克的影响。将导管插入Sprague-Dawley大鼠的股动脉和静脉。首先,给予溶解于0.5 ml蒸馏水中的沙格雷酯0(对照)、3或10 mg/kg,5分钟后再给予溶解于0.5 ml生理盐水中的内毒素10 mg/kg。监测每剂量20只大鼠的血压、脉搏率和存活率。测量每剂量8只大鼠的血气和血浆细胞因子浓度。对沙格雷酯0、3或10 mg/kg组以及假手术组各4只大鼠进行肺组织学检查。对照组、3 mg/kg组和10 mg/kg组分别有0、15和12只大鼠存活8小时。对照组的血压、脉搏率、pH值和动脉血氧分压最低,动脉血二氧化碳分压和血浆IL-1β浓度最高。3 mg/kg组TNF-α的升高明显低于对照组。3和10 mg/kg组肺的病理变化受到抑制。总之,沙格雷酯可能有效减少促炎细胞因子的产生,维持血流动力学,抑制肺损伤,并降低内毒素休克的死亡率。